Effect of DPP-4 inhibitor on beta cell protectio
Not Applicable
- Conditions
- Type 2 diabetes mellitus
- Registration Number
- JPRN-UMIN000004689
- Lead Sponsor
- Clinical Research Center,National Hospital Organization
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 1200
Inclusion Criteria
Not provided
Exclusion Criteria
1)Patients with type 1 diabetes mellitus 2)Patients who developed diabetic ketoacidosis,or diabetic pre-and coma within 24 weeks of the study entry. 3)Patients with severe infections or severe trauma or perioperative state. 4)Patients with renal insufficiency (CrCl=and>30mL/min, Serum creatinine=and>Male:1.5mg/dl,Female:1.3mg/dl) 5)Patients who received insulin therapy. 6) Patients with severe complication in cardiovascular system within 24 weeks before study entry. 7) Patients with pregnancy, possibility of pregnancy or having a breast feeding. 8)Patients who had a history of hypersensitive reaction to sitagliptin. 9)Patients who are deemed to be inappropriate by the investigator.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method